Europe Peritoneal Dialysis Market

The Europe peritoneal dialysis market is projected to reach 2.72 billion by 2031 from USD 2.20 billion in 2026, at a CAGR of 4.3%.

The Europe peritoneal dialysis market is expanding due to the rising incidence of end-stage renal disease (ESRD), increased adoption of home-based therapies, supportive reimbursement reforms, and the availability of automated peritoneal dialysis systems. However, market growth is constrained by limited patient and caregiver awareness, insufficient training infrastructure, the risk of peritonitis, and uneven adoption of peritoneal dialysis across countries. At the same time, growth opportunities are emerging from the expansion of telehealth-enabled remote monitoring, ongoing technological advancements in automated peritoneal dialysis machines, strong economic and clinical incentives for home-based care, and government initiatives promoting dialysis outside traditional clinical settings, particularly in Western and Northern Europe.

This report segments the peritoneal dialysis market by offering, modality, disease indication, end user, and region.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in this market include Vantive Health LLC (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US), Utah Medical Products, Inc. (US), Terumo Corporation (Japan), Diaverum AB (Sweden), Medionics (Canada), Newsol Technologies (Canada), Apollo Dialysis Pvt Ltd (India), U.S. Renal Care, Inc. (US), Northwest Kidney Centers (US), Relavo (US), JMS Co., Ltd. (Japan), AMECATH (Egypt), Huaren Pharmaceutical (China), AWAK Technologies (Singapore), Innovative Renal Care (US), and Renax Biomedical Technology Co., Ltd (China).

Vantive Health LLC (US)

Vantive Health LLC, formerly Baxter's Kidney Care business, is a significant stakeholder in the Europe peritoneal dialysis market due to its historical leadership of peritoneal dialysis (PD) solutions, the accompanying fluids, and automated peritoneal dialysis (APD) systems, such as HomeChoice Claria, which are widely applied in renal centers across Europe. Vantive benefits from a well-established distribution business, along with relationships built with dialysis clinics and strong training programs for home-based dialysis. Another strength of Vantive is the massive installed base, product reliability, and meaningful innovations in remote monitoring and patient-centric PD systems. The long-standing strength from the Baxter days and large-scale operations now continue to mark Vantive as one of the most critical players in shaping the PD landscape in Europe.

Fresenius Medical Care AG (Germany)

Fresenius Medical Care AG stands out as one of the top companies in the Europe peritoneal dialysis market, with its vast renal care structure and diversified product portfolio, along with its deep clinical integration across the continent. Since Fresenius is the largest dialysis service provider on the European continent, it operates numerous renal clinics, thereby allowing for the greater use and deployment of PD systems, such as Stay Safe and Sleep Safe. Centrally coordinated vertical integration of PD solutions, consumables, devices, and patient training leads to high therapeutic continuity and uniform application of the same standards. Strong distribution capabilities, close long-term partnerships with many hospitals, and funding for home-dialysis innovation, including digital monitoring platforms, enhance its leadership position. Its clinical knowledge and broad patient base, accompanied by a strong commitment to home-based treatment, have culminated in one of the most influential shapes in the Europe peritoneal dialysis market.

Medtronic plc (Ireland)

Medtronic plc is a key player in the European peritoneal dialysis market, holding technologies related to peritoneal access and catheters, which are essential for initiating and maintaining PD therapy. Although not a full-line PD solutions manufacturer like Fresenius or Vantive, it is a major player supplying high-quality Tenckhoff catheters, laparoscopic placement tools, and surgical devices widely used in hospitals, primarily in Europe. These products are instrumental in achieving safe and reliable implantation of catheters, significantly influencing PD adoption and outcomes for patients. With its firm leadership in minimally invasive surgery, broad relationships that foster clinical innovations, and continuing advances in surgical instrumentation, Medtronic distinguishes itself as a strong enabler of scaling PD therapy across Europe, delivering procedures efficiently while striving to reduce complications.

Market Ranking

The Europe peritoneal dialysis market is competitive, with prominent players accounting for 39.2% of the total market share in 2025. Some key players dominating the market include Vantive Health LLC (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), and Becton, Dickinson and Company (US), among others.

European leaders in the peritoneal dialysis (PD) market are often seen focusing principally on developed countries such as Germany, France, Italy, and the UK, where a solid renal care infrastructure, well-established networks of dialysis, and favorable reimbursement systems have supported greater adoption of PD. However, over the last couple of years, some smaller regional players and catheter manufacturers have begun to enter the market with PD consumables and access devices tailored to meet local clinical needs. In doing so, these new entrants are challenging global leaders even more with competitive pricing and differentiated focus through their catheter technologies and services. With this shift toward home dialysis being fueled by telehealth and value-based care, a significant opportunity arises for both incumbent players and new entrants to strengthen their positions and expand their reach across the region.

Related Reports:

Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals): Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com